Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,867,474
+$1,850,844 QoQ
Shares Held
17,900
+62.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#273
of 1,031 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $14,801,650 across 7 Drug Manufacturers - General names. BIIB ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
252,400 | $6,077,792 | |
| 2 | BIIB |
Biogen Inc.
This page
|
17,900 | $3,867,474 | |
| 3 | SNY |
Sanofi
|
57,100 | $2,435,886 | |
| 4 | NVO |
Novo Nordisk A S
|
27,000 | $1,294,380 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,648 | $587,228 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,140 | $403,490 | |
| 7 | OGN |
Organon & Co.
|
10,000 | $135,400 |
All Filings in BIIB
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,867,474 | 17,900 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,016,630 | 11,000 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $4,276,557 | 24,300 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $2,521,440 | 18,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $640,509 | 5,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $615,780 | 4,500 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $465,641 | 3,045 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,742,510 | 29,625 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||